Agilon Health, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ryan Langston from TD Cowen maintained a Hold rating on the stock and has a $1.00 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Ryan Langston has given his Hold rating due to a combination of factors impacting Agilon Health’s financial outlook. The company’s recent quarterly performance was affected by lower than anticipated risk adjustment revenues and high costs in markets they exited, leading to a significant miss in EBITDA expectations. Despite these challenges, Agilon Health has taken steps to address data issues and reduce operating expenses, which could stabilize future performance.
Looking ahead, the company anticipates several strategic improvements, such as better-aligned payer contracts and disciplined cost management, which are expected to enhance financial results. However, potential headwinds from changes in the ACO REACH program and a focus on margin over membership growth could limit upside potential. Given these mixed signals, Langston maintains a cautious stance with a Hold rating, reflecting both the challenges and opportunities facing Agilon Health.
According to TipRanks, Langston is an analyst with an average return of -4.8% and a 43.75% success rate. Langston covers the Healthcare sector, focusing on stocks such as UnitedHealth, Elevance Health, and Molina Healthcare.
In another report released today, Evercore ISI also maintained a Hold rating on the stock with a $0.50 price target.